chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Took steroid shot at the back after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of STEROID ACTIVITY (Took steroid shot at the back after 1st dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced STEROID ACTIVITY (Took steroid shot at the back after 1st dose). At the time of the report, STEROID ACTIVITY (Took steroid shot at the back after 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were not provided.  Treatment medication was not provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments
pt devel t105 w/in 24 hrs of vax w/inc irritability & unconsolable crying lasting approx 24 hrs;
Rash which developed 6 days post vaccination, affected left arm and subsequently involved nearly entire body. No new medications, foods, exposures. Patient was treated with Depo Medrol injection and steroid cream. Still minimal amount of rash present on left arm.
Swelling at site and surrounding area/ blotchy/tenderness to touch/large knot/painful/low grade fever - day after
Redness and Itching on neck, face, scalp, lips, chest, eventually turning into hives.
My arm was sore, itchy, red, blotchy and swollen and had bumps like bite on it.
Most serious was 7 days after vaccine ,both eyes swollen, red,itchy eyes, scalp and neck itched uncontrollably. Swollen lymph nodes in left side neck for first 4 days. I could feel the eye swelling comming on for 2 days before it got worst. Joint pains with both vaccines  #1 and #2. Also nausea.
Mild headache turned into moderate to severe lightheaded & dizziness 5 days post vaccine. Still ongoing  Inability to focus.   Fatigue.
Complained of fever, headache with visual disturbance. Nausea and body aches 1 day after shot.
8-12 hours after pt received vaccination, she couldn't stand up (described as her legs were dead) and had a temperature
I became really happy and had great amounts of energy for several days after my first dose of Pfizer.; I became really happy and had great amounts of energy for several days after my first dose of Pfizer.; This is a spontaneous report received from a contactable consumer. The reporter is the patient.  A 65 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 30Mar2021 (Lot number: ER8730) at the age of 65 years (as reported) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Sciatica" (unspecified if ongoing); "Migraines" (unspecified if ongoing). Concomitant medication(s) included: AMITRIPTYLINE; ESZOPICLONE; RISPERIDONE; TRAZODONE. Past drug history included: Droperidol, reaction(s): "Drug allergy"; Cogentin, reaction(s): "Drug allergy"; Seroquel, reaction(s): "Drug allergy"; Frova, reaction(s): "Drug allergy". The following information was reported: ENERGY INCREASED (non-serious), THERAPEUTIC RESPONSE UNEXPECTED (non-serious) all with onset Mar2021, outcome "recovered" (Mar2021) and all described as "I became really happy and had great amounts of energy for several days after my first dose of Pfizer.". Therapeutic measures were not taken as a result of energy increased, therapeutic response unexpected.  Additional information: The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On an unspecified date (Mar2021), the patient became really happy and had great amounts of energy for several days after first dose vaccine. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event.  No follow-up attempts are possible. No further information is expected.
Conjunctivitis; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Aug-2021 and was forwarded to Moderna on 09-Aug-2021.    This spontaneous case was reported by a physician and describes the occurrence of CONJUNCTIVITIS (Conjunctivitis) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CONJUNCTIVITIS (Conjunctivitis). At the time of the report, CONJUNCTIVITIS (Conjunctivitis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.   Reporter did not allow further contact
Rash on inner from armpit to wrist itchy, red, blotchy; Rash on inner from armpit to wrist itchy, red, blotchy; Rash on inner from armpit to wrist itchy, red, blotchy; This is a spontaneous report from a contactable consumer (patient). A 80-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Batch/Lot Number: Elo142), via an unspecified route of administration on 21Jan2021 at 12:00 PM as a single dose for covid-19 immunisation at Doctor's office/urgent care. The patient medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks. On 21Jan2021, the patient experienced rash on inner from armpit to wrist itchy, red, blotchy. No treatments were received for events. The patient was not recovered from the events.   Follow-up attempts are completed. No further information is expected.
One week post administration of DTaP in left thigh. Mom reported a large area of erythema at site of injection. Treated for probable cellulitis.
no additional AEs,; PNEUMOVAX 23 was administered to a patient on 03/28/2023 and the vaccine expired on 01/29/2023.; This spontaneous report was received from a registered nurse (RN) and referred to a 3-year-old patient of unknown gender. The patient's medical history, concurrent conditions, concomitant therapies and drug reaction/allergies were not reported.   On 28-MAR-2023, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, once, expiration date: 29-JAN-2023, administered for prophylaxis (lot # was unknown by reporter; dose, strength and route of administration were not provided) (expired product administered). No additional adverse events.
Patient had dizziness, extreme headache and muscle and join pain as well as diarrhea on the second dose of the vaccine. The symptoms about a day and half.
11DEC fever 100 R & sleep for 2 days;12DEC broke out w/ fine red rash all over body which intensified 13DEc & 14DEC;rash 15DEC the same on body, but inc on face;looks like measles & fever;inc activity today & itching;
A 4 year old, female patient developed injection site reaction after receiving Daptacel, in the left leg on 08/15/2005.  The patient also received Ipol and MMR, in the left leg on the same day.  On 08/16/2005 she had left leg swelling, tenderness and itchiness.  There was a swollen length of the leg.  She was seen by her doctor on 08/17/2005 and treated with Tylenol and Benadryl.  It was not reported if the patient recovered. Followup information received on 09/12/2005.  The patient recovered from this event.  No further information is expected.
29may90 pt vax hepta B. 30may90 pt devel pain in left arm, shoulder, and scapular area. treated w/ motrin and physc. therapy. 29jun90 2nd vax. pt ex n/ chills, h/a and feverish feeling. sx resolved by 03jul90.
fully vaccinated (pfizer, 2/8/21, 3/1/21); symptom onset 7/31/21
Severe pain in right arm that spreads to neck and shoulder. Right fingers swollen and tingly.
As soon as I got the injection I felt my tongue burning/tingling and then tasted a heavy metallic taste in my mouth.  It lasted the whole day.  It subsided after I ate later in the evening and then dissipated by the next day.   Four days later I started to experience burning "Pins and Needles" feeling that would start from my left forearm down to my fingertips then I would feel it in my left foot in the toes.  I could not sleep the whole night.  The next day the pins and needles feeling intensified.  It would hit all throughout my body on both sides.  Then I could feel numbness in my fingers and toes.  Working on the computer started to feel daunting like I couldn't even move the mouse on the computer.  I had no motivation.  When getting up, my body felt like Jello.  I reported this to my family Dr, on Tues. 6/15/21.  I am still feeling the symptoms today.
Red, itchy face with mild burning feeling, swollen throat with itch, and tingling in tongue.
ask if not feeling is the side effects from her second dose of the covid-19 vaccine which she got yesterday; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 26Mar2021 (Batch/Lot number: unknown) as dose 2, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162B2 (dose 1), administration date: 04Mar2021, for COVID-19 immunisation. The following information was reported: HYPOAESTHESIA (non-serious) with onset Mar2021, outcome "unknown", described as "ask if not feeling is the side effects from her second dose of the covid-19 vaccine which she got yesterday".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
HE WOKE UP THE FOLLOWING DAY AFTER VACCINATION IM WITH PAIN LOCALIZED ON LOWER 1/3 OF LEFT AXILLA , SAME SIDE OF DELTOID MUCLE . AREA IS SWOLLEN , NO MASS IS PALPATED. OVERLYING SKIN IS NORMAL.AREA OF VACCINATION IS NORMAL WITH MINIMAL TENDERNESS.NO FEVER.PATIENT IS TAKING ADVIL 400 MG PO BID
24 hours after vaccines, patient started getting irritable. Was subsequently hospitalized for a U/A. 2 MRI of the head UGI with small amount of GERD A follow up report received 6/11/2003 adds: Fussy, incosolable. Diagnosed with GERD.
Three days after injection,  in morning I noticed three to four postule irruptions near left collarbone burbubg, oozing, red and very Itchy.  Thought at first, it was a skin irritation and treated as such.  Now, two weeks later still same condition and told it is a recurrence of shingles. I had as in same location and same appearance.  A rare side effect of vaccine!
Pt recv vax on 7/13/98; on 7/24/98 pt exp fever>101.5, swollen neck glands, lethargic, fatigue, swollen joints, difficulty moving, sore; pt imp 8/10/98
Information has been received from a consumer and a nurse practitioner concerning the consumer's 6-year-old white daughter with a sulfonamide allergy and allergies, who on 28-AUG-2000 was vaccinated subcutaneously in the right arm with a dose of Varivax (Lot # 634842/1867J). Concomitant therapy included Allegra and sodium fluoride. On 19-APR-2006 (also reported as 02-MAY-2006) the patient experienced breakthrough chickenpox. No medical attention was sought; no laboratory or diagnostic tests were performed. The outcome was reported as recovered, as of 24-APR-2006. No product quality complaint was involved. There were no relevant diagnostic tests or laboratory data. Follow up information indicated that the patient ended up getting strep throat. It was reported that the patient's brother experienced an adverse event following vaccination (WAES# 0604USA03970). No additional information is expected.
Information has been received from a clinical medical assistant referring to multiple unspecified patients of unknown age and gender. The patients' pertinent medical histories or drug reactions/allergies were not reported. On unknown dates the patients were vaccinated with improperly stored doses of VARIVAX (lot # L007225 with expiration date 03-MAR-2017; dose and route were not reported). No adverse effects were reported. This is one of the several cases from the same reporter. Additional information has been requested.
Patient developed severe abdominal pain Sunday night and was admitted to the hospital for treatment of acute pancreatitis.
Approximately 12 am, February 28, I started to have alternating chills and fever all through the night until around 6am .  Throughout the day on Feb. 28th, I had a headache and felt lethargic until my headache started to abate around 6pm.  By March 1st., the adverse symptoms had gone.
Fever, chills (lasted 5 days), arm tenderness, feeling weak and fatigued on first day. 2nd day developed hives that was hot to the touch (that lasted 5 days) chest pains, heart palpatations, sore throat and itchy watery eyes.
COVID-19 arm. Raised hard circle at injection site. Hard, painful and warm to touch. Very itchy.
Day 7-8 after injection, injection site became red, itchy and painful to touch.
Patient reported red, itchy rash around injection site started approximately 2 days after receiving PREVNAR 13 (received vaccine on 05/03/18. Patient went to ER on 05/10/18 with c/o rash and was not admitted. Discharged home with prescriptions for BENADRYL and prednisone with resolution of symptoms.
Approximately, 1 minute after vaccine was given pt. stated she felt nauseous and saw black spots. Pt. started swaying, blacked out and passed out.
Headache; Nausea; Fatigue; Soreness; BP higher than normal; This spontaneous case was reported by an other health care professional and describes the occurrence of HEADACHE (Headache), NAUSEA (Nausea), FATIGUE (Fatigue), PAIN (Soreness) and HYPERTENSION (BP higher than normal) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced HEADACHE (Headache), NAUSEA (Nausea), FATIGUE (Fatigue), PAIN (Soreness) and HYPERTENSION (BP higher than normal). At the time of the report, HEADACHE (Headache), NAUSEA (Nausea), FATIGUE (Fatigue), PAIN (Soreness) and HYPERTENSION (BP higher than normal) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Jan-2021, SARS-CoV-2 test: negative (Negative) Negative. On 12-Jan-2021, SARS-CoV-2 test: negative (Negative) Negative. On 21-Jan-2021, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included Birth control, multi vitamins.  Treatment information was not provided.
Woke up next morning,  I had taken a Tylenol the night before. Swelling of arm at vaccination site, reddness,  pain, and slight headache
Information has been received from a health professional concerning a 19 year old female with an allergy to DEMEROL, morphine and penicillin who on 11-OCT-2007 was vaccinated with her first dose of GARDASIL (lot# 658563/1063U). On 03-JAN-2008 the patient was vaccinated with her second dose of GARDASIL (lot# 659439/1267U). On 07-MAY-2008 the patient was vaccinated with her third dose of GARDASIL (lot# 660389/1968U). The third dose may have been administered subcutaneously. Concomitant therapy included YASMIN. On 07-MAY-2008, within 15 minutes of the dose, the patient experienced burning and redness at the injection site. The patient was being treated with BENADRYL, antibiotics and cool compresses applied to the injection site. The patient was seen in the office and her outcome was unknown. Additional information has been requested.
Developed all symptoms of COVID Tongue after 2nd dose vaccine. White tongue, ulcers, very sensitive gums and sores on lips. Gum sensitivity started on day 2, other symptoms started on day 3. I am currently on day 5 and still have all above listed symptoms. I had a phone Dr. consult this morning and will be picking up some anti-viral meds this afternoon.
Potassium was too high; chest pain; This is a spontaneous report from A contactable consumer (patient's wife) reported that a male patient of an unspecified age (husband) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration on 25Feb2021 (batch/lot number was not reported) as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The consumer was calling on behalf of her husband. Her husband got his first dose (25Feb2021) and his second dose schedule was on 18Mar2021. It's just that the patient missed his second dose and didn't make it because he's in the hospital because his potassium was too high and having chest pain on an unspecified date, was planning for a reschedule for his second dose. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Severe headache, nausea, body aches, dizziness, muscle aches, joint pain,upset stomach got the flu shot at the same time in right arm?
This spontaneous report received from a consumer, concerns herself a female patient, of unspecified age, who received the Moderna COVID-19 vaccine (mRNA-1273) and experienced: didn't feel well and tested positive for COVID-19. The patient's medical history and concomitant medications not reported. On Jan 17, 2021, prior to the onset of the events the patient received the first of two planned doses of mRNA-1273 (batch/lot# unknown), via unknown route, for prophylaxis of COVID-19 infection. On Jan 17, 2021, patient experienced the event(s) didn't feel well. On Jan 22, 2021, patient experienced the event: tested positive for COVID-19. No treatment information provided. Action taken with mRNA-1273 in response to the events not reported. The outcome of didn't feel well and tested positive for COVID-19: unknown.
Patient recieved the first pfizer vaccine on 3/15 and tolerated without side effect. On 4/5/21 he recieved the 2nd vaccine and 72 hrs later he felt extremely weak sweaty had some nausea and then developed the swelling over the temples on 4/12 he had no visual loss he had no headaches he had no PMR type symptoms. He developed  neck pain shoulder pain or hip girdle pain.  He had no visual changes. he was referred to our office with a high sed rate and elevated glucose. Saw Dr 4/26/21 for initial evaluation. pt was started on prednisone, temporal swelling had already resolved.
This spontaneous report was received from a healthcare professional, referring to multiple unspecified patients of unknown age and gender. Information regarding the patients' pertinent medical history, concurrent conditions, known allergies and concomitant medications was not reported. On an unknown date, the patients were vaccinated with an improperly stored dose of ROTATEQ orally, with lot # L020859 and expiration date on 19-JAN-2017 and with lot # L023870 with expiration date on 20-APR-2017 for prophylaxis. It was stated that, ROTATEQ, was exposed to a temperature of > 8°C but < 25°C, for a 677 hours time frame. Data logger was involved. Furthermore, ROTATEQ was never exposed to previous temperature excursions and a product quality issue was not reported. No adverse effects were suffered. This is one of several reports received from the same reporter. Additional information is not expected as consent to follow up was not provided. Sender's Comments: US-009507513-1702USA009046: US-009507513-1702USA009047: US-009507513-1702USA009048.
Within approx 25 minutes after FLUZONE, felt a seering hot pain down left arm for a second and went away. Then went to office, noticed left great thumb swelling within 1 1/2 hours. 24 hrs. later, still the same size. Has used ice.
Information has been received from a  registered nurse concerning a 30 week old infant who was vaccinated 20-NOV-2006 with an oral dose of Rotateq. No problems were reported. It was not reported if medical attention was sought. There was no product quality involved. Additional information is not expected.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 25-SEP-2015, the patient was vaccinated with improperly stored (Oka/Merck) PROQUAD with lot number: L026728, expiry date: 15-JAN-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Pt had hives all over her body few hours after received this vaccine on 9/24/20 at 1:10pm.  Hives was developed around 6-7pm with itchiness and worse around 9pm.  Hives started fading around 3am and gone by 5-6am.  Then hives repeated with the same pattern for 4 days around the same time.  Hives finally resolved on 9/28/20.
Shortly after administering vaccine. Pt started to display fainting symptoms. Pt fell to his knees. Mom held him up and with help from nursing staff, carried him onto the medical bed. Elevated his feet. Charge Nurse was informed and she took his Blood Pressure. Blood Pressure reading was within normal range. Pt was being monitored for 15 minutes. Was able to sit up and converse. Pt was stable and alert. Pt was discharged from clinic @ 11:14am.
Patient describes waking in the middle of the night after receiving Fluad with shortness of breath lasting about 2 minutes.
Left upper, outer arm swelling, redness, warmth.  Began evening of vaccination 07/21/2003 and still present 07/23/2003.  Swelling appears to be resolving.
STARTING SEP 2- PT HAD JOINT PAIN AT DIFFERENT JOINTS EACH DAY, SOMETIMES THE KNESS, SOMETIMES THE HANDS, SOMETIMES SWOLLEN WRISTS
10 days after MMR Fever 102 and decreased appetite, red face and rash on trunk. And evolved to rash of the hands and feet, with swelling of the hands and feet. Fever lasted 2 days Today (9/29/14) patient presents with swollen left jaw. Consistent with parotitis. (Parotitis started 15 days post vaccine). rash has improved
This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 74-year-old female patient who received SHINGRIX for prophylaxis. On 26th December 2018, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a month after receiving SHINGRIX, the patient experienced influenza-like symptoms and joint pain. On an unknown date, the outcome of the influenza-like symptoms and joint pain were recovered/resolved. It was unknown if the reporter considered the influenza-like symptoms and joint pain to be related to SHINGRIX. Additional details were reported as follows: The patient had flu-like symptoms after getting the SHINGRIX. The patient mentioned joint aches specifically. The patient was out of commission for a couple days.